• HempFusion Wellness Inc. is currently in the process of applying for OTCQX listing and DTC eligibility after a swift and strategic move to enter the OTC Pink Market under the ticker symbol ‘CBDHF’
• Wholly owned subsidiary Probulin Probiotics recently released Total Care Immune probiotic, which is expected to reach retailer shelves in February 2021
• Probulin is recognized as one of the fastest-growing probiotic brands in the American Natural Products Industry
• January, HempFusion received USDA Organic Certification for its CBD tinctures

In a strategic move to broaden the United States investor audience, health and wellness company HempFusion Wellness (TSX: CBD.U) (OTC: CBDHF) (FWB: 8OO) has announced that it has secured an OTC Markets ticker, ‘CBDHF,’, its common shares have commenced trading on the OTC Pink Market and it has already begun the process of applying for an OTCQX uplisting and DTC eligibility. According to HempFusion’s Co-founder and CEO, Jason Mitchell N.D., this is an important step for the U.S.-based cannabidiol company, as it enables access to a broader range of U.S. investors (https://ibn.fm/3KrNK).

A leading health and CBD company that utilizes the power of whole-food hemp nutrition, HempFusion is also the first U.S.-based CBD & Wellness products company to list directly on the Toronto Stock Exchange, a process it completed earlier this year, under the ticker symbol ‘CBD.U.’

HempFusion’s products include a family of brands such as HempFusion, Probulin Probiotics, Biome Research and HF Labs, that are already distributed in approximately 4,000 retail locations throughout the US as well as select international locales. In addition, the company has identified an approximate 26,000-store target pipeline to distribute its products. The company is planning to expand operations and potentially add a larger variety of products, including CBD-based beverages, edibles, pet products and more.

Earlier in January, the company announced the launch of a new product, the Total Care Immune probiotic, through its wholly-owned subsidiary, Probulin Probiotics, LLC. Total Care Immune probiotic is expected to reach major retailers’ shelves, including Sprouts Farmers Markets, Abby’s, and Fresh Thyme Markets, in February 2021. Online sales are currently available through the company website (https://ibn.fm/alrIH).

The Total Care Immune probiotic uses the power of elderberry and combines it with the daily digestive and immune support of pre-, pro-, and post-biotics for a unique offering. The product includes:

• 100 mg of Eldermune(TM) (the equivalent to 4,425 mg whole elderberry);
• 20 billion CFU, including 8 billion CFU from fermented fruits and vegetables;
• Scientific formulation using 10 probiotic strains such as lactobacillus acidophilus, lactobacillus reuteri, lactobacillus rhamnosus, and bifidobacterial lactis;
• Probiotic + Prebiotics + Postbiotics for complete microbiome support; and
• Probulin’s proprietary MAKtrek(R) 3-D Probiotic Delivery System to ensure better survival.

According to SPINs syndicated data, Probulin is recognized as one of the fastest-growing probiotics brands in the American Natural Products Industry. All of the Probulin products represent a class of next-generation probiotics for digestive and immune health and support based on cultured food and scientifically studied strains.

The new launch followed another major announcement in January: receiving USDA Organic Certified status for the company’s tinctures. HempFusion began the approval process in 2018. The CBD potency of these certified tinctures ranges from 150 mg (5 mg per serving) to 1500 mg (50 mg per serving) per bottle. The certification makes HempFusion one of the first publicly traded CBD companies to receive such a high distinction (https://ibn.fm/3eC8t).

The certification process to be classified USDA Organic is a rigorous process that requires detailed documentation for every step in the growth, production, and manufacturing process. HempFusion was responsible for documenting down to the finest detail what was in the soil used to grow the hemp, how it was extracted, all the way to how the finished products are manufactured and bottled. HempFusion was also required to undergo independent facility and documentation audits to earn the USDA Organic seal’s exclusive honor.

“Our team has worked meticulously to earn USDA Organic Certification, which supports our commitment to providing consumers with premium and differentiated CBD products as well as new potential distribution points,” Mitchell commented. “This prestigious certification joins our many other compliance markers, further establishing HempFusion as a leader in the premium CBD category.”

For more information, visit the company’s website at www.HempFusion.com/corporate-information.

NOTE TO INVESTORS: The latest news and updates relating to HempFusion are available in the company’s newsroom at https://ibn.fm/CBDHF 

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.